![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
Korea Otsuka Pharmaceutical Co.,Ltd. Otsuka Pharmaceutical Co., Ltd. |
Information provided by: | Korea Otsuka Pharmaceutical Co.,Ltd. |
ClinicalTrials.gov Identifier: | NCT00549978 |
to investigate the safety and pharmacokinetics, in healthy adult male subjects
Condition | Intervention | Phase |
Healthy |
Drug: Cilostazol Drug: Probucol |
Phase IV |
ChemIDplus related topics: | Cilostazol Probucol |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Crossover Assignment, Pharmacokinetics Study |
Official Title: | Phase IV, Safety and Pharmacokinetics of Probucol and Cilostazol When Coadministered in Healthy Subjects |
Estimated Enrollment: | 32 |
Study Start Date: | October 2007 |
Estimated Study Completion Date: | December 2007 |
Arms | Assigned Interventions |
1
Two compartments with cross-over and parallel
|
Drug: Cilostazol
cilostazol, then cilostazol/probucol
|
2
Two compartments with cross-over and parallel
|
Drug: Probucol
Probucol probucol/ cilostazol
|
Safety and Pharmacokinetics of Probucol and Cilostazol when co-administered in Health Subjects
Ages Eligible for Study: | 20 Years to 40 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Yonghui Jeong | 82-2-3465-3956 | jeongyh@otsuka.co.kr |
Contact: Boyoun Seo | 82-2-3465-5485 | byseo@otsuka.cokr |
Korea, Republic of | |||||
Clinical Trial Center, Seoul National University Hospital | Recruiting | ||||
Seoul, Korea, Republic of, 110-744 | |||||
Principal Investigator: In-Jin Jang |
Korea Otsuka Pharmaceutical Co.,Ltd. |
Otsuka Pharmaceutical Co., Ltd. |
Principal Investigator: | In-Jin Jang, PhD | Seoul National University Hospital |
Study ID Numbers: | 021-KOB-0702 |
First Received: | October 25, 2007 |
Last Updated: | November 13, 2007 |
ClinicalTrials.gov Identifier: | NCT00549978 |
Health Authority: | South Korea: Institutional Review Board |
|
|
|
|
![]() |